Robert F. Apple

2009

In 2009, Robert F. Apple earned a total compensation of $493.2K as Chief Financial Officer at Antares Pharma, a 3% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$72,000
Option Awards$60,825
Salary$291,862
Stock Awards$60,227
Other$8,250
Total$493,164

Apple received $291.9K in salary, accounting for 59% of the total pay in 2009.

Apple also received $72K in non-equity incentive plan, $60.8K in option awards, $60.2K in stock awards and $8.3K in other compensation.

Rankings

In 2009, Robert F. Apple's compensation ranked 6,912th out of 9,885 executives tracked by ExecPay. In other words, Apple earned more than 30.1% of executives.

ClassificationRankingPercentile
All
6,912
out of 9,885
30th
Division
Manufacturing
2,546
out of 3,690
31st
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
393
out of 607
35th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
218
out of 331
34th
Industry
Surgical and Medical Instruments and Apparatus
143
out of 217
34th
Source: SEC filing on April 13, 2012.

Apple's colleagues

We found three more compensation records of executives who worked with Robert F. Apple at Antares Pharma in 2009.

2009

Paul Wotton

Antares Pharma

Chief Executive Officer

2009

Dario Carrara

Antares Pharma

Managing Director, Pharmaceutical Group

2009

Peter Sadowski

Antares Pharma

Chief Technology Officer

News

You may also like